Necrobiosis Lipoidica Study

  • Home
  • Necrobiosis Lipoidica Study

Necrobiosis Lipoidica Study Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Necrobiosis Lipoidica Study, Medical and health, .

The goal of this research study is to test PCS499 (the investigational drug) compared to placebo to see if it is safe and if it works as the sponsor believes it might.

Ulcerations can occur in up to 30% of patients with Necrobiosis Lipoidica (NL) and can prove challenging to treat. There...
05/12/2022

Ulcerations can occur in up to 30% of patients with Necrobiosis Lipoidica (NL) and can prove challenging to treat. There are currently no FDA-approved treatments for NL. Click here to learn more about a clinical trial investigating the treatment of ulcerations of patients with NL. https://necrobiosislipoidicastudy.com/

Find a physician near you who is participating in a new study to evaluate a potential new treatment for open ulcers due ...
09/11/2022

Find a physician near you who is participating in a new study to evaluate a potential new treatment for open ulcers due to Necrobiosis Lipoidica.

Necrobiosis Lipoidica (NL) is a rare, painful condition affecting the skin and tissue under the skin; it typically affects the lower legs.

There is NO COST to participate in the clinical trial to evaluate PCS499 in treating  ulcerations in patients with Necro...
17/10/2022

There is NO COST to participate in the clinical trial to evaluate PCS499 in treating ulcerations in patients with Necrobiosis Lipoidica (NL). The medication and care you receive is FREE. Processa Pharmaceuticals will cover travel costs (air, train, hotel, etc) for patient’s needing to travel to clinical sites.
https://necrobiosislipoidicastudy.com

Processa Pharmaceuticals has initiated a randomized, double blind, placebo controlled study that will evaluate the effic...
03/10/2022

Processa Pharmaceuticals has initiated a randomized, double blind, placebo controlled study that will evaluate the efficacy and safety of PCS499 (an investigational oral medication from Processa Pharmaceuticals) as compared to placebo for the treatment of ulcerations of patients with Necrobiosis Lipoidica (NL). Click here to learn more https://necrobiosislipoidicastudy.com/

Do you suffer from open ulcers due to Necrobiosis Lipoidica?  Click here to see if you might qualify for a clinical stud...
19/09/2022

Do you suffer from open ulcers due to Necrobiosis Lipoidica? Click here to see if you might qualify for a clinical study looking at a new treatment

NL is an inflammatory condition in which shiny, red-brown or yellowish patches develop in the skin. Patches of NL usually start as one or more small, red, slightly raised areas on front side of one or both lower legs.

Address


Alerts

Be the first to know and let us send you an email when Necrobiosis Lipoidica Study posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram